Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.

[1]  Srinivasan Vijayakumar,et al.  Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. , 2008, International journal of radiation oncology, biology, physics.

[2]  C. Yiannoutsos,et al.  Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[3]  J R Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet.

[4]  Lech Papiez,et al.  Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[5]  R. Timmerman,et al.  Stereotactic body radiation therapy for early-stage non-small-cell lung cancer , 2008, Expert review of anticancer therapy.

[6]  R. Mcgarry,et al.  Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience. , 2006, International journal of radiation oncology, biology, physics.

[7]  Lech Papiez,et al.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Ping Li,et al.  Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[9]  W. Mühlnickel,et al.  Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases , 2006, Radiation oncology.

[10]  J. Beitler,et al.  Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. , 2006, International journal of radiation oncology, biology, physics.

[11]  Jan Nyman,et al.  Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries , 2006, Acta oncologica.

[12]  Masahiro Hiraoka,et al.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.

[13]  Lech Papiez,et al.  Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. , 2005, International journal of radiation oncology, biology, physics.

[14]  Branislav Jeremic,et al.  Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. , 2005, Lung cancer.

[15]  T. Araki,et al.  Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.

[16]  M. Hiraoka,et al.  Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience , 2004, International Journal of Clinical Oncology.

[17]  Michael Flentje,et al.  Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. , 2004, International journal of radiation oncology, biology, physics.

[18]  D. Rades,et al.  Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Stephanie Frost,et al.  Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. , 2003, Chest.

[20]  M. Nishimura,et al.  Small‐volume image‐guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas , 2002, Cancer.

[21]  Jeffrey E. Lee,et al.  Adjuvant irradiation for axillary metastases from malignant melanoma. , 2001, International journal of radiation oncology, biology, physics.

[22]  C. Willett,et al.  Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  G. Tsumatori,et al.  Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients , 1998, Cancer.

[24]  C. Willett,et al.  Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer , 1995, Journal of surgical oncology.

[25]  D. Shreiner.  Textbook of Physical Diagnosis, History and Examination , 1995, Journal of General Internal Medicine.

[26]  N. K. Olsen,et al.  Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. , 1993, International journal of radiation oncology, biology, physics.

[27]  A. Recht,et al.  Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer. , 1993, International journal of radiation oncology, biology, physics.

[28]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[29]  J. K. Martin,et al.  Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  A. Salner,et al.  Reversible brachial plexopathy following primary radiation therapy for breast cancer. , 1981, Cancer treatment reports.

[31]  K. Foley,et al.  Brachial plexus lesions in patients with cancer=100 cases , 1981, Neurology.

[32]  J. Hendry,et al.  Radiobiology for the Radiologist , 1979, British Journal of Cancer.

[33]  T. Delaney,et al.  Lumbosacral plexopathy secondary to hyperfractionated radiation therapy: A case presentation and literature review , 1993 .

[34]  F. Vicini,et al.  Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. , 1992, International journal of radiation oncology, biology, physics.